Clinical Trials
81 trialsTRIBE-C
Sun Yat-sen University
PREOPANC-3
Erasmus Medical Center
PHITT
University of Birmingham
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Alliance for Clinical Trials in Oncology
LAP100
NRG Oncology
MEND-IT II
Catharina Ziekenhuis Eindhoven
SOLARIS
Alliance for Clinical Trials in Oncology
FOBEAR
Sun Yat-sen University
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
Alliance for Clinical Trials in Oncology
CAPRI-3 GOIM
University of Campania Luigi Vanvitelli
NB-NK-2026
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
GRECCAR8
Hospices Civils de Lyon
AIO-KRK-0418
Charite University, Berlin, Germany
PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer
Sun Yat-sen University
Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
City of Hope Medical Center
AtezoTRIBE2
Gruppo Oncologico del Nord-Ovest
NEXT-REGIRI
Institut du Cancer de Montpellier - Val d'Aurelle
IROCAS
UNICANCER
LEFT-PANC
Helsinki University Central Hospital
The Sagittarius Trial
IFOM ETS - The AIRC Institute of Molecular Oncology
CinClare
Fudan University
PTCA199-11
Fudan University
OSCAR
Federation Francophone de Cancerologie Digestive
FIRE-11
Charite University, Berlin, Germany
EFFIPEC
Uppsala University
PANThEON
Gruppo Oncologico del Nord-Ovest
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
AIO-KRK-0114
Ludwig-Maximilians - University of Munich
Pre-Operative Treatment in REseCTable COlon CanceR
Charite University, Berlin, Germany
CAIRO5
Dutch Colorectal Cancer Group
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Alliance for Clinical Trials in Oncology
IMPROVE-2
National Cancer Institute, Naples
Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC
Sun Yat-sen University
Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer
Fudan University
Escape
Sun Yat-sen University
Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM
Sun Yat-sen University
NEOPAN
UNICANCER
FANTASTIC
Sun Yat-sen University
BRAZIL-TNT
Hospital Israelita Albert Einstein
RIDER
Sun Yat-sen University
FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
Sun Yat-sen University
TRIPLETE
Gruppo Oncologico del Nord-Ovest
Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer
Stanford University
AFFORD
Sun Yat-sen University
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
University of Leeds
RCNAC
Fudan University
Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer
UNICANCER
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Alliance for Clinical Trials in Oncology